MCID: TYP007
MIFTS: 58

Typhoid Fever malady

Categories: Rare diseases, Infectious diseases, Gastrointestinal diseases

Aliases & Classifications for Typhoid Fever

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 2CDC, 65UMLS, 27ICD10, 29ICD9CM, 42NCIt, 59SNOMED-CT, 28ICD10 via Orphanet
See all MalaCards sources

Aliases & Descriptions for Typhoid Fever:

Name: Typhoid Fever 10 45 47 12 51 36 2 65
Typhoid 10 45 51
Diverticulosis of Colon with Hemorrhage 10
 
Typhoidal Salmonellosis 51
Typhoid Infection 10
Enteric Fever 45

Characteristics:

Orphanet epidemiological data:

51
typhoid fever:
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe),>1/1000 (South East Asia),1-5/10000 (Latin America),1-5/10000 (Africa),1-9/1000000 (North America),1-5/10000 (Oceania),1-9/1000000 (France); Age of onset: All ages; Age of death: adolescent,late childhood

Classifications:



External Ids:

Disease Ontology10 DOID:13258
ICD1027 A01.0, A01.00
ICD9CM29 002.0
MeSH36 D014435
NCIt42 C35089
Orphanet51 99745
ICD10 via Orphanet28 A01.0
UMLS65 C0041466

Summaries for Typhoid Fever

About this section
Disease Ontology:10 A primary bacterial infectious disease that is a communicable systemic illness, has material basis in Salmonella enterica subsp enterica serovar Typhi, which is transmitted by ingestion of food or water contaminated with the feces of an infected person. The infection has symptom fever, has symptom diarrhea, has symptom prostration, has symptom headache, has symptom splenomegaly, has symptom liver enlargement, has symptom eruption of rose-colored spots, and has symptom leukopenia.

MalaCards based summary: Typhoid Fever, also known as typhoid, is related to peyronie's disease and tracheal stenosis, and has symptoms including hallucinations, abdominal pain and migraine. An important gene associated with Typhoid Fever is SLC11A1 (Solute Carrier Family 11 Member 1), and among its related pathways are LDL Oxidation in Atherogenesis and HIF-1 signaling pathway. The drug ciprofloxacin has been mentioned in the context of this disorder. Affiliated tissues include liver, skin and colon, and related mouse phenotypes are tumorigenesis and liver/biliary system.

Wikipedia:68 Typhoid fever, also known simply as typhoid, is a bacterial infection due to Salmonella typhi that... more...

Related Diseases for Typhoid Fever

About this section

Diseases related to Typhoid Fever via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 551)
idRelated DiseaseScoreTop Affiliating Genes
1peyronie's disease30.5IL1B, TNF
2tracheal stenosis30.3IFNG, IL1B, TNF
3fatty liver disease30.0CFTR, CRP, F2, TNF
4heart disease30.0CRP, F2, IL1B, TLR4
5meningitis29.9CRP, IL1B, TLR4, TNF
6dextrocardia29.8CFTR, IFNG, IL1B, TNF
7rheumatoid arthritis29.2CASP1, CRP, IFNG, IL1B, SLC11A1, TLR4
8systemic lupus erythematosus29.2CRP, IFNG, LTA, TLR5, TNF
9typhoidal tularemia12.4
10invasive non-typhoidal salmonellosis12.3
11diverticulitis of colon11.7
12paratyphoid fever10.6
13hepatitis10.5
14polycythemia10.5IL1B, TNF
15autoimmune oophoritis10.5IFNG, TNF
16chagas disease10.4TLR4, TNF
17typhus10.4
18intermediate congenital nemaline myopathy10.4IFNG, IFNGR1
19stargardt macular degeneration absent or hypoplastic corpus callosum mental retardation and dysmorphic features10.4IL1B, TNF
20non-distal monosomy 10q10.4IFNG, TNF
21plantar nerve lesion10.4IL1B, TNF
22hair defect with photosensitivity and mental retardation10.4OMP, TNF
23mammary paget's disease10.4IL1B, TNF
24parasitic ichthyosporea infectious disease10.4IFNG, TNF
25lymphoma10.4
26prostatitis10.4
27adenocarcinoma10.4
28gonococcal bursitis10.4IFNG, TNF
29spinal polio10.4IFNG, TLR4
30waardenburg syndrome type 410.4IL1B, TNF
31ileocolitis10.4TLR4, TLR5, TNF
32basilar artery occlusion10.4TLR4, TLR5, TNF
33endotheliitis10.3
34protein r deficiency10.3IL1B, TLR4
35conventional malignant hemangiopericytoma10.3IFNG, OMP, TNF
36rhinoscleroma10.3CRP, TNF
37cervicitis10.3
38tethered spinal cord syndrome10.3IFNG, IFNGR1, TNF
39scleritis10.3IFNGR1, TLR4
40opisthorchiasis10.3IFNG, TNF
41rubeosis iridis10.3IL1B, TLR4, TNF
42auricular cancer10.3IL1B, TLR4, TNF
43anti-hla hyperimmunization10.3TLR4, TNF
44postauricular lymphadenitis10.3CRP, IL1B
45idiopathic spinal cord herniation10.3IL1B, TLR4, TNF
46acute gonococcal epididymo-orchitis10.3IFNG, TLR4, TNF
47sarcoidosis, early-onset10.3IL1B, TLR4, TNF
48submandibular gland disease10.3IL1B, TLR4, TNF
49uterine corpus epithelioid leiomyoma10.3IFNG, IFNGR1, TNF
50necatoriasis10.3IFNG, TLR4, TNF

Graphical network of the top 20 diseases related to Typhoid Fever:



Diseases related to typhoid fever

Symptoms for Typhoid Fever

About this section

Symptoms:

 51 10 (show all 36)
  • epigastralgia/heartburn/gastric/duodenal ulcer/gastritis
  • acute abdominal pain/colic
  • facial pain/cephalalgia/migraine
  • insomnia
  • delirium/hallucination
  • fever/chilling
  • asthenia/fatigue/weakness
  • cutaneous rash
  • macules
  • hepatomegaly/liver enlargement (excluding storage disease)
  • splenomegaly
  • cardiac rhythm disorder/arrhythmia
  • ataxia/incoordination/trouble of the equilibrium
  • hypertonia/spasticity/rigidity/stiffness
  • hypereflexia
  • myalgia/muscular pain
  • articular/joint pain/arthralgia
  • acute diarrhea
  • constipation
  • gastrointestinal bleeding/hemorrhage/hematemesis/melena/rectorrhagia
  • intestinal perforation
  • cough
  • interstitial/restrictive pneumopathy/restrictive respiratory syndrome
  • collapse/sudden death/cardiac arrest/cardiorespiratory arrest
  • venous thrombosis/phlebitis/thrombophlebitis
  • encephalitis
  • tremor
  • obnubilation/coma/lethargia/desorientation
  • epistaxis/nose bleeding
  • fever
  • diarrhea
  • prostration
  • headache
  • liver enlargement
  • eruption of rose-colored spots
  • leukopenia

HPO human phenotypes related to Typhoid Fever:

(show all 25)
id Description Frequency HPO Source Accession
1 hallucinations hallmark (90%) HP:0000738
2 abdominal pain hallmark (90%) HP:0002027
3 migraine hallmark (90%) HP:0002076
4 abnormality of the gastric mucosa hallmark (90%) HP:0004295
5 abnormality of temperature regulation hallmark (90%) HP:0004370
6 insomnia hallmark (90%) HP:0100785
7 skin rash typical (50%) HP:0000988
8 hypermelanotic macule typical (50%) HP:0001034
9 hypertonia typical (50%) HP:0001276
10 hyperreflexia typical (50%) HP:0001347
11 splenomegaly typical (50%) HP:0001744
12 hepatomegaly typical (50%) HP:0002240
13 incoordination typical (50%) HP:0002311
14 arthralgia typical (50%) HP:0002829
15 myalgia typical (50%) HP:0003326
16 epistaxis occasional (7.5%) HP:0000421
17 tremor occasional (7.5%) HP:0001337
18 sudden cardiac death occasional (7.5%) HP:0001645
19 diarrhea occasional (7.5%) HP:0002014
20 constipation occasional (7.5%) HP:0002019
21 restrictive lung disease occasional (7.5%) HP:0002091
22 gastrointestinal hemorrhage occasional (7.5%) HP:0002239
23 encephalitis occasional (7.5%) HP:0002383
24 reduced consciousness/confusion occasional (7.5%) HP:0004372
25 thrombophlebitis occasional (7.5%) HP:0004418

Drugs & Therapeutics for Typhoid Fever

About this section

Drugs for Typhoid Fever (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 44)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CefiximeapprovedPhase 42079350-37-154362, 5362065
Synonyms:
(-)-Cefixim
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b
79350-37-1
7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
AB00513842
AC-4350
AC1NSFNI
BPBio1_000622
BRD-K71059170-001-02-5
BSPBio_000564
C06881
CEFIXIME
CFIX
CHEBI:472657
CHEBI:530642
CHEMBL1541
CID5362065
CL-284635
 
Cefixim
Cefixima
Cefixima [Spanish]
Cefixime (JP15/USP/INN)
Cefixime Anhydrous
Cefiximum
Cefiximum [Latin]
Céfixime
D00258
Denvar
FK-027
FR-17027
LS-187248
MLS002222332
MolPort-003-845-687
NCGC00179521-01
Necopen
Prestwick3_000462
SMR001307271
Suprax
Suprax (TN)
Tricef
2
AzithromycinapprovedPhase 4, Phase 332283905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
3
CeftriaxoneapprovedPhase 411073384-59-55479530, 5361919
Synonyms:
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
104376-79-6
104376-79-6 (di-hydrochloride salt)
73384-59-5
74578-69-1 (di-hydrochloride salt, hemiheptahydrate)
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
AC-1592
AC1NUIFE
Biotrakson
C06683
C18H18N8O7S3
CEFTRIAXONE SODIUM
CHEBI:29007
CHEMBL161
CID5479530
CTRX
Cefatriaxone
Ceftriaxon
Ceftriaxona
Ceftriaxona [INN-Spanish]
Ceftriaxone
 
Ceftriaxone (INN)
Ceftriaxone (TN)
Ceftriaxone [USAN:JAN]
Ceftriaxone intravenous
Ceftriaxone, Disodium Salt
Ceftriaxone, Disodium Salt, Hemiheptahydrate
Ceftriaxonum
Ceftriaxonum [INN-Latin]
Ceftriazone
D07659
DB01212
DRG-0071
EINECS 277-405-6
LS-150031
Longacef
Longaceph
MolPort-005-933-495
Ro 139904
Ro-13-9904
Ro13-9904
Rocefin
Rocephin
Rocephine
UNII-75J73V1629
ceftriaxone
4
Gatifloxacinapproved, investigationalPhase 431112811-59-35379
Synonyms:
(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
112811-59-3
160738-57-8
180200-66-2
AC-1944
AC1L1K82
AKOS004119932
AM 1155
AM-1155
AM-1155 (*Sesquihydrate*)
BB_SC-1123
BMS 206584-01
BMS-206584
BMS-206584-01
BRD-A74980173-001-02-8
BSPBio_002697
Bonoq
C07661
CG 5501
CG-5501
CHEBI:5280
CHEMBL31
CID5379
CPD000043336
D08011
DB01044
FT-0082686
GTFX
Gaity
Gatiflo
Gatiflo,Tequin and Zymar, Gatifloxacin
Gatifloxacin
Gatifloxacin & Gamma Interferon
Gatifloxacin (INN)
Gatifloxacin (TN)
Gatifloxacin [USAN:INN]
Gatifloxacine
Gatifloxacino
Gatifloxacinum
 
Gatilox
Gatiquin
Gatispan
HMS1922J15
HMS2090K10
HMS2093G06
I06-2286
I06-2287
KBio2_002442
KBio2_005010
KBio2_007578
KBio3_001917
KBioGR_001613
KBioSS_002448
Kinome_3137
LS-184402
MLS000040259
MLS000759493
MolPort-001-738-626
NCGC00095126-01
NCGC00095126-02
NCGC00178525-01
PD 135432
PD-135432
PD135432
S1340_Selleck
S1340_Sellekc
SAM001246715
SAM002589955
SMR000043336
SPBio_000353
SPECTRUM1504272
STK801620
Spectrum2_000487
Spectrum3_000999
Spectrum4_001127
Spectrum5_001468
Spectrum_001909
TL8001438
Tequin
Tequin in dextrose 5% in plastic container
Zymar
Zymaxid
Zymer
Zymer (TN)
5Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
6VaccinesPhase 4, Phase 3, Phase 2, Phase 1, Phase 06085
7Anti-Infective AgentsPhase 4, Phase 3, Phase 1, Phase 217220
8Antitubercular AgentsPhase 41061
9Anti-Bacterial AgentsPhase 4, Phase 39140
10Antibiotics, AntitubercularPhase 45971
11Topoisomerase InhibitorsPhase 44081
12FluoroquinolonesPhase 4242
13Nucleic Acid Synthesis InhibitorsPhase 43836
14
SulfamethoxazoleapprovedPhase 3139723-46-65329
Synonyms:
129378-89-8
3-(Para-Aminophenylsulphonamido)-5-methylisoxazole
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(para-Aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-Benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide
4-Amino-N-[5-methyl-3- isoxazolyl]benzenesulfonamide
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
46850_RIEDEL
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
723-46-6
A047
AB00052099
AC-11118
AC1L1K42
AC1Q2J5R
AKOS000200952
ALBB-002089
ARONIS018156
Apo-Sulfamethoxazole
Azo Gantanol
Azo-Gantanol
Azo-gantanol
BAS 00836086
BB_SC-1251
BIDD:GT0731
BPBio1_000081
BRD-K28494619-001-05-0
BRN 0226453
BSPBio_000073
BSPBio_002028
Bactrim
Bactrimel
C07315
C10H11N3O3S
CAS-723-46-6
CCRIS 567
CHEBI:9332
CHEMBL443
CID5329
CPD000058223
D00447
D013420
DB01015
DivK1c_000649
EINECS 211-963-3
Gamazole
Gantanol
Gantanol (TN)
Gantanol (tn)
Gantanol-DS
HMS1568D15
HMS1921A21
HMS2092K03
HMS502A11
HMS561O18
HSDB 3186
I01-0154
IDI1_000649
InChI=1/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)
KBio1_000649
KBio2_001474
KBio2_004042
KBio2_006610
KBio3_001528
KBioGR_000749
KBioSS_001474
LS-1620
MLS000069732
MLS001055354
MLS001074165
MS 53
Maybridge1_007190
Metoxal
MolPort-000-145-787
N'-(5-Methyl-3-isoxazole)sulfanilamide
 
N'-(5-Methyl-3-isoxazolyl)-Sulfanilamide
N'-(5-Methyl-3-isoxazolyl)sulfanilamide
N'-(5-Methylisoxazol-3-yl)sulphanilamide
N(Sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide
N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
N1-(5-Methylisoxazol-3-yl)sulfanilamide
N1-(5-methyl-3-isoxazolyl)-Sulfanilamide
NCGC00016533-01
NCGC00016533-02
NCGC00021995-03
NCGC00021995-04
NCGC00021995-05
NINDS_000649
NSC 147832
NSC147832
N^1-(5-Methyl-3-isoxazolyl)-Sulfanilamide
Ndimethyl1-(5-methyl-3-isoxazolyl)-Sulfanilamide
Oprea1_114486
Oprea1_285680
Prestwick0_000177
Prestwick1_000177
Prestwick2_000177
Prestwick3_000177
Prestwick_453
Radonil
Ro 4-2130
Ro 6-2580/11
Ro-4-2130
S0361
S1915_Selleck
S7507_FLUKA
S7507_SIGMA
SAM002554930
SIM
SMR000058223
SMX
SPBio_000896
SPBio_001994
SPECTRUM1500550
STK007988
SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE)
Septran
Simsinomin
Sinomin
Solfametossazolo
Solfametossazolo [DCIT]
Spectrum2_000788
Spectrum3_000584
Spectrum4_000345
Spectrum5_000982
Spectrum_000994
Sulfamethalazole
Sulfamethoxazol
Sulfamethoxazole
Sulfamethoxazole (JP15/USP/INN)
Sulfamethoxazole [USAN:INN:JAN]
Sulfamethoxazole sodium
Sulfamethoxazole(USAN)
Sulfamethoxazolum
Sulfamethoxazolum [INN-Latin]
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfametoxazol [INN-Spanish]
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- (8CI)
Sulfisomezole
Sulpha-Methoxizole
Sulpha-methoxizole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulphamethylisoxazole
Sulphisomezole
TL8005058
TMP/SMX (MIXTURE))
Trib
UNII-JE42381TNV
Urobak
WLN: T5NOJ C1 EMSWR DZ
ZINC00089763
nchembio.221-comp24
sulfamethoxazole
15
TrimethoprimapprovedPhase 3153738-70-55578
Synonyms:
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
46984_FLUKA
46984_RIEDEL
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
738-70-5
92131_FLUKA
92131_SIGMA
AB00052118
AB1004879
AC-13572
AC1L1KNQ
AC1Q48DF
AI3-52594
AKOS001650069
ARONIS24118
AZT + TMP/SMX (mixture) combination
Abacin
Abaprim
Alcorim-F
Alprim
Anitrim
Antrima
Antrimox
Apo-Sulfatrim
BB_SC-2116
BIDD:GT0190
BPBio1_000215
BRD-K07208025-001-06-5
BRN 0625127
BSPBio_000195
BSPBio_002245
BW 56-72
BW 5672
BW-56-72
Bacdan
Bacidal
Bacide
Bacin
Bacta
Bacterial
Bacterial [Antibiotic]
Bacticel
Bactin
Bactoprim
Bactramin
Bactrim
Bactrim DS
Bactrim Pediatric
Baktar
Bencole
Bethaprim
Biosulten
Briscotrim
C01965
CAS-738-70-5
CCRIS 2410
CHEBI:45924
CHEMBL22
CID5578
CPD0-1581
CPD000035999
Chemotrim
Chemotrin
Cidal
Co-Trimoxizole
Co-trimoxazole
Colizole
Colizole DS
Comox
Conprim
Cotrim
Cotrim D.S.
Cotrimel
D00145
D014295
DB00440
Deprim
DivK1c_000589
Drylin
Duocide
EINECS 212-006-2
EU-0101271
Esbesul
Espectrin
Euctrim
Eusaprim
Exbesul
Fectrim
Fermagex
Fortrim
Futin
Gantaprim
Gantrim
HMS1568J17
HMS1921I03
HMS2090D14
HMS2092A10
HMS501N11
HSDB 6781
I06-0086
IDI1_000589
Idotrim
Ikaprim
Imexim
Instalac
Ipral
KBio1_000589
KBio2_000647
KBio2_003215
KBio2_005783
KBio3_001465
KBioGR_000863
KBioSS_000647
KSC-4-158
KUC103659N
Kepinol
Kombinax
LS-1627
Lagatrim
Lagatrim Forte
Laratrim
Lastrim
Lidaprim
Linaris
Lopac-T-7883
Lopac0_001271
MLS000079023
MLS001201740
MLS002303068
Methoprim
Metoprim
Microtrim
MolPort-001-826-685
Monoprim
Monotrim
Monotrimin
NCGC00016055-01
NCGC00016055-02
NCGC00016055-06
NCGC00016055-12
NCGC00024707-01
NCGC00024707-03
NCGC00024707-04
NCGC00024707-05
NCGC00024707-06
NCGC00024707-07
NCGC00024707-08
NIH 204
 
NIH 204 (VAN)
NINDS_000589
NSC 106568
NSC-106568
NSC106568
Nopil
Novotrimel
Omstat
Oprea1_495058
Oraprim
Pancidim
Polytrim
Prestwick0_000208
Prestwick1_000208
Prestwick2_000208
Prestwick3_000208
Prestwick_485
Priloprim
Primosept
Primsol
Proloprim
Proloprim (TN)
Protrin
Purbal
Resprim
Resprim Forte
Roubac
Roubal
SAM002264649
SMP2_000262
SMR000035999
SPBio_000874
SPBio_002116
SPECTRUM1500595
STK177322
Salvatrim
Septra
Septra DS
Septra Grape
Septrin
Septrin DS
Septrin Forte
Septrin S
Setprin
Sigaprim
Sinotrim
Smz-Tmp
Spectrum2_000937
Spectrum3_000643
Spectrum4_000372
Spectrum5_001559
Spectrum_000167
Stopan
Streptoplus
Sugaprim
Sulfamar
Sulfamethoprim
Sulfamethoprim-DS
Sulfamethoxazole & Trimethoprim
Sulfatrim
Sulfatrim Pediatric
Sulfatrim-DS
Sulfatrim-SS
Sulfotrim
Sulfoxaprim
Sulmeprim
Sulmeprim Pediatric
Sulprim
Sulthrim
Sultrex
Sumetrolim
Supracombin
Suprim
Syraprim
T 7883
T2286
T7883_SIGMA
TCMDC-125538
TL8005108
TMP/SMX (MIXTURE))
Teleprim
Thiocuran
Tiempe
Tmp-Ratiopharm
Tocris-0650
Toprim
Trigonyl
Trimanyl
Trimesulf
Trimeth/Sulfa
Trimethioprim
Trimethopim(TMP)
Trimethoprim
Trimethoprim & VRC3375
Trimethoprim (JAN/USP/INN)
Trimethoprim [USAN:BAN:INN:JAN]
Trimethoprime
Trimethoprime [INN-French]
Trimethoprimum
Trimethoprimum [INN-Latin]
Trimethopriom
Trimetoprim
Trimetoprim [DCIT]
Trimetoprim [Polish]
Trimetoprima
Trimetoprima [INN-Spanish]
Trimexazole
Trimexol
Trimez-IFSA
Trimezol
Trimogal
Trimono
Trimopan
Trimpex
Trimpex (TN)
Trimpex 200
Triméthoprime
Triprim
Trisul
Trisulcom
Trisulfam
Trisural
U-Prin
UNII-AN164J8Y0X
UPCMLD-DP132
UPCMLD-DP132:001
Unitrim
Uretrim
Uro-D S
Uro-Septra
Urobactrim
Uroplus
Uroplus DS
Uroplus SS
Utetrin
Velaten
WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1
WR 5949
Wellcoprim
Wellcoprin
Xeroprim
ZINC06627681
Zamboprim
component of Bactrim
component of Septra
nchembio.108-comp1
nchembio.215-comp11
nchembio.221-comp23
trimethoprim
16Antiprotozoal AgentsPhase 3, Phase 1, Phase 21730
17Antiparasitic AgentsPhase 3, Phase 1, Phase 21854
18
LactitolPhase 3, Phase 2320585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
19Trimethoprim, Sulfamethoxazole Drug CombinationPhase 3157
20AntimalarialsPhase 31058
21
ZincapprovedPhase 1, Phase 214777440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
22
AlbendazoleapprovedPhase 1, Phase 27254965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
23
Vitamin Aapproved, nutraceuticalPhase 241311103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(2e,4e,6e,8e)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Chocola a
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A palmitate
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin a
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
24
FormaldehydeexperimentalPhase 27350-00-0712
Synonyms:
Aldeide formica
Fannoform
Formaldehyde
Formalina
Formaline
Formalith
Formic aldehyde
Formol
 
Methaldehyde
Methanal
Methyl aldehyde
Methylene glycol
Methylene oxide
Oxomethane
Oxomethylene
Oxymethylene
Paraform
Paraformaldehyde
25Tubulin ModulatorsPhase 1, Phase 24279
26Trace ElementsPhase 1, Phase 23900
27SecnidazolePhase 1, Phase 25
28Liver ExtractsPhase 1, Phase 23572
29Zinc SulfatePhase 1, Phase 264
30Heptavalent Pneumococcal Conjugate VaccinePhase 2440
31ImmunoglobulinsPhase 24477
32Retinol palmitatePhase 2413
33MicronutrientsPhase 1, Phase 23901
34AntibodiesPhase 24477
35Pharmaceutical SolutionsPhase 1, Phase 2, Phase 07004
36AnthelminticsPhase 1, Phase 2379
37Dermatologic AgentsPhase 1, Phase 24555
38Antimitotic AgentsPhase 1, Phase 24296
39retinolNutraceuticalPhase 2413
40LecithinNutraceuticalPhase 1, Phase 263
41Soy BeanNutraceuticalPhase 1, Phase 2455
42
PectinPhase 1299000-69-5441476
Synonyms:
(+)-Xylose
2,3,4,5-Tetrahydroxypentanal
D-Lyxose
DL-Xylose
L(+)-Xylose
 
L-Lyxose
Lyxose
Pectin
Pectin sugar
Pectinose
Pentose
Trobicin
43BCG Vaccine99
44CantharidinPhase 08

Interventional clinical trials:

(show all 46)
idNameStatusNCT IDPhase
1Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central VietnamCompletedNCT00131820Phase 4
2Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, ChinaCompletedNCT00131833Phase 4
3Evaluation of the Vi Polysaccharide Vaccine Against Typhoid FeverCompletedNCT00125008Phase 4
4Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in ChildhoodCompletedNCT00125047Phase 4
5Typhoid Fever: Combined vs. Single Antibiotic TherapyRecruitingNCT02224040Phase 4
6Cross-reactive Immunity Elicited by Oral and Parenteral Typhoid VaccinesRecruitingNCT02121145Phase 4
7Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric FeverActive, not recruitingNCT01421693Phase 4
8Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese SubjectsCompletedNCT01608815Phase 3
9A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsCompletedNCT01466387Phase 3
10Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & ImmunogenicityCompletedNCT00197249Phase 3
11Improving Rotavirus Vaccine Immune ResponseCompletedNCT01825109Phase 3
12Nepal Undifferentiated Febrile Illness TrialNot yet recruitingNCT02773407Phase 3
13Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in InfantsCompletedNCT00342628Phase 2
14Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult SubjectsCompletedNCT00498654Phase 2
15Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy AdultsCompletedNCT00679172Phase 2
16TY800 Dose Escalation (Typhoid)CompletedNCT00269295Phase 1, Phase 2
17Studies of Immune Responses to Orally Administered Vaccines in Developing CountryCompletedNCT01019083Phase 1, Phase 2
18Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in AdultsCompletedNCT01438996Phase 2
19Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)CompletedNCT01193907Phase 2
20Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and InfantsCompletedNCT01229176Phase 2
21Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and InfantsCompletedNCT01437267Phase 2
22Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy SubjectsCompletedNCT00875524Phase 2
23Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma PatientCompletedNCT02338700Phase 1, Phase 2
24Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma PatientCompletedNCT02338804Phase 1, Phase 2
25Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma PatientCompletedNCT02338778Phase 1, Phase 2
26Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma PatientCompletedNCT02338752Phase 1, Phase 2
27Vaccines Against Salmonella TyphiRecruitingNCT02324751Phase 2
28Understanding Typhoid Disease After VaccinationActive, not recruitingNCT01405521Phase 2
29Vaccines and Dietary Oats in the Treatment of Ulcerative ColitisTerminatedNCT00751933Phase 2
30CVD 909 Vi Prime Boost StudyCompletedNCT00326443Phase 1
31Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate VaccineCompletedNCT00277147Phase 1
32Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)CompletedNCT01123941Phase 1
33Influence of Dietary Nitrate on Vascular Dysfunction and InflammationRecruitingNCT02715635Phase 1
34Safety and Immunogenicity of a Vi-DT Typhoid Conjugate VaccineNot yet recruitingNCT02645032Phase 1
35Investigating the Effects of Typhoid Vaccine on Sleep in Healthy VolunteersCompletedNCT02628054
36Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of AgeCompletedNCT00386789
37Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder PatientsCompletedNCT01533285Phase 0
38Role of BCG as Booster VaccinationCompletedNCT02175420
39Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge StudyRecruitingNCT02192008
40Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer Who Received ChemotherapyRecruitingNCT02415387
41Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among TravelersRecruitingNCT02391909
42Investigation of the Influence of Gender on Cardiovascular FunctionRecruitingNCT01582321Phase 0
43Causes of Fever in Bangladeshi PatientsRecruitingNCT02339259
44Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)Active, not recruitingNCT01766830
45Understanding Paratyphoid InfectionActive, not recruitingNCT02100397
46Impact of Immune Challenge on Triple Network Connectivity in HumansNot yet recruitingNCT02653235

Search NIH Clinical Center for Typhoid Fever

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: typhoid fever

Genetic Tests for Typhoid Fever

About this section

Anatomical Context for Typhoid Fever

About this section

MalaCards organs/tissues related to Typhoid Fever:

33
Liver, Skin, Colon, Breast, Lung, Testes, Prostate

Animal Models for Typhoid Fever or affiliated genes

About this section

MGI Mouse Phenotypes related to Typhoid Fever:

38 (show all 15)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.4CASP1, IFNG, IFNGR1, IL1B, SLC11A1, TLR4
2MP:00053708.2CFTR, IFNG, IFNGR1, LTA, TLR4, TLR5
3MP:00107718.1CASP1, F2, IFNG, IFNGR1, IL1B, TLR4
4MP:00053898.0CASP1, CFTR, F2, IFNG, IFNGR1, TLR4
5MP:00053797.9CASP1, CFTR, IFNG, IFNGR1, LTA, TLR5
6MP:00053887.5CFTR, F2, IFNG, LTA, OMP, TLR4
7MP:00053817.5CASP1, CFTR, F2, IFNG, IFNGR1, SLC11A1
8MP:00053907.4F2, IFNG, IFNGR1, IL1B, LTA, TLR4
9MP:00036316.9CASP1, F2, IFNG, IFNGR1, IL1B, LTA
10MP:00053856.3CASP1, CRP, F2, IFNG, IFNGR1, IL1B
11MP:00107685.8CASP1, CFTR, F2, IFNG, IFNGR1, IL1B
12MP:00053875.6CASP1, CFTR, CRP, F2, IFNG, IFNGR1
13MP:00053975.4CASP1, CFTR, F2, IFNG, IFNGR1, IL1B
14MP:00053765.2CASP1, CFTR, CRP, F2, IFNG, IFNGR1

Publications for Typhoid Fever

About this section

Articles related to Typhoid Fever:

(show top 50)    (show all 596)
idTitleAuthorsYear
1
Application of Droplet Digital PCR to Validate Rift Valley Fever Vaccines. (27076132)
2016
2
Elevated serum fibrinogen: an independent link between diabetes mellitus, impaired on-clopidogrel platelet inhibition, and major adverse cardiac events after percutaneous coronary intervention. (25908081)
2015
3
Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris. (24316592)
2014
4
EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation. (24648348)
2014
5
Association between I^2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS. (22900502)
2013
6
Are major basic protein, eotaxin-3 and leukotriene enzyme staining useful for diagnosing eosinophilic esophagitis? (Am j gastroenterol 2012;107:1503-1511). (23350059)
2013
7
Effects of a recreational ice skating program on the functional mobility of a child with cerebral palsy. (24328904)
2013
8
One Lung Wheezing due to Endobronchial Solitary Papilloma. (24171131)
2013
9
Combining ESI, ASL and PET for quantitative assessment of drug-resistant focal epilepsy. (23792219)
2013
10
Association of HLA-G 3' untranslated region polymorphisms with antibody response against Plasmodium falciparum antigens: preliminary results. (23745572)
2013
11
Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents. (21981993)
2012
12
Pertussis outbreaks and pertussis vaccines: new insights, new concerns, new recommendations? (23141958)
2012
13
Continuous motor monitoring enhances functional preservation and seizure-free outcome in surgery for intractable focal epilepsy. (20437060)
2010
14
Study of sand fly fauna in an endemic area of American cutaneous leishmaniasis and canine visceral leishmaniasis in the municipality of EspA-rito Santo do Pinhal, SALo Paulo, Brazil. (20428683)
2010
15
Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. (19937601)
2009
16
Development of an acquired Chiari malformation Type I in the setting of an untreated lipomyelomeningocele. Case report. (18352791)
2008
17
Cognitive dietary restraint: impact on bone, menstrual and metabolic status in young women. (18508099)
2008
18
Keloids: A viral hypothesis. (17509771)
2008
19
MR imaging-based evidence of vasogenic brain edema in a case of acute acetone intoxication. (18202235)
2008
20
Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-talk between MyD88 and FAK pathways. (18292575)
2008
21
A method for production of recombinant mCD1d protein in insect cells. (18989404)
2007
22
Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer. (17519070)
2007
23
p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. (16051807)
2005
24
Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy. (15532013)
2005
25
Effects of Choto-san and its related constituents on endogenous antioxidant systems. (15635163)
2005
26
Searching for evidence: Refractory questions in advanced heart failure. (15190530)
2004
27
Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. (14996736)
2004
28
A novel splice site mutation in the WAS gene causes Wiskott-Aldrich syndrome in two siblings of a Saudi family. (15389128)
2004
29
Dysautonomia in chronic fatigue syndrome: facts, hypotheses, implications. (14962627)
2004
30
Influence of Th1, Th2, and Th3 cytokines during the early phase after liver transplantation. (14697968)
2003
31
Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. (11890677)
2002
32
Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. (10608745)
2000
33
Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. (10902765)
2000
34
Liposome targeting to tumors using vitamin and growth factor receptors. (11037627)
2000
35
Unusual renal features of Lowe syndrome in a mildly affected boy. (11146467)
2000
36
DREAM is a Ca2+-regulated transcriptional repressor. (10078534)
1999
37
Gi proteins use a novel beta gamma- and Ras-independent pathway to activate extracellular signal-regulated kinase and mobilize AP-1 transcription factors in Jurkat T lymphocytes. (10391949)
1999
38
Intussusception secondary to Meckel's diverticulum detection with Tc-99m monoclonal antibodies to granulocytes (Leukoscan). (8922842)
1996
39
Expression of the human interleukin-2 receptor gamma chain in insect cells using a baculovirus expression vector. (7899821)
1995
40
The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1): a cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1-alpha 4 integrin interaction. (7539925)
1995
41
Echinostomiasis in India. (8613177)
1994
42
Distinct and overlapping functions of allelic forms of human mannose binding protein. (1303250)
1992
43
Microcephalic osteodysplastic primordial dwarfism and cephalo-skeletal dysplasia (Taybi-Linder syndrome) (1605263)
1992
44
Analysis of choroideraemia gene. (1904992)
1991
45
Treatment of septic olecranon and prepatellar bursitis with percutaneous placement of a suction-irrigation system. A report of 12 cases. (3011340)
1986
46
Galactorrhoea following hypophysectomy in a boy with a prolactinoma. (6540876)
1984
47
A unique patient with coexisting cerebrotendinous xanthomatosis and beta-sitosterolemia. (7258222)
1981
48
Urology-epitomes of progress: recent experience in the management of fournier gangrene. (18748404)
1979
49
Acute bloat syndrome (gastric dilatation) in Macaca mulatta. (4981377)
1969
50

Variations for Typhoid Fever

About this section

Expression for genes affiliated with Typhoid Fever

About this section
Search GEO for disease gene expression data for Typhoid Fever.

Pathways for genes affiliated with Typhoid Fever

About this section

Pathways related to Typhoid Fever according to GeneCards Suite gene sharing:

(show all 49)
idSuper pathwaysScoreTop Affiliating Genes
19.8IL1B, TNF
29.6IFNG, IFNGR1, TLR4
3
Show member pathways
9.5IL1B, TLR4, TLR5
49.5IFNG, IFNGR1, IL1B
59.5CASP1, IL1B
69.5IL1B, TLR4, TNF
79.5IFNG, IL1B, TNF
89.5IFNG, IL1B, TNF
99.5IFNG, IL1B, TNF
109.5IFNG, IL1B, TNF
119.2IFNG, IFNGR1, IL1B, TNF
129.2CASP1, IL1B, TNF
13
Show member pathways
9.2IFNG, IL1B, TLR4, TLR5
149.1IFNG, IL1B, TLR4, TNF
159.1IFNG, IL1B, TLR4, TNF
169.1IFNG, IL1B, TLR4, TNF
179.1IFNG, IL1B, TLR4, TNF
189.1IFNG, IL1B, TLR4, TNF
199.0LTA, TLR4, TNF
209.0IFNG, IFNGR1, TLR4, TLR5, TNF
219.0IL1B, LTA, TNF
22
Show member pathways
8.9F2, IFNG, IL1B, TNF
23
Show member pathways
8.9IFNG, IFNGR1, IL1B, TLR4, TNF
248.9IFNG, IFNGR1, IL1B, TLR4, TNF
25
Show member pathways
8.9IFNG, IFNGR1, IL1B, TLR4, TNF
26
Show member pathways
8.9CASP1, IFNG, IFNGR1, IL1B
278.9CASP1, IL1B, TLR4, TNF
288.8LTA, TLR4, TLR5, TNF
29
Show member pathways
8.8IFNG, IFNGR1, LTA, TNF
308.7IL1B, LTA, TLR4, TNF
318.6IFNG, IL1B, LTA, TNF
32
Show member pathways
8.6IFNG, IL1B, LTA, TNF
33
Show member pathways
8.6IFNG, IFNGR1, IL1B, TLR4, TLR5, TNF
34
Show member pathways
8.6IFNG, IFNGR1, IL1B, TLR4, TLR5, TNF
358.6CASP1, IL1B, TLR4, TLR5, TNF
36
Show member pathways
8.5CRP, F2, IFNG, IL1B, TNF
37
Show member pathways
8.4IL1B, LTA, TLR4, TLR5, TNF
38
Show member pathways
8.4IFNG, IFNGR1, IL1B, LTA, TNF
39
Show member pathways
8.3IFNG, IFNGR1, IL1B, LTA, TNF
40
Show member pathways
8.2CFTR, IFNG, IFNGR1, IL1B, TLR4, TLR5
41
Show member pathways
8.1CFTR, IFNG, IFNGR1, IL1B, TLR4, TLR5
42
Show member pathways
8.1CASP1, CFTR, IL1B, TLR4, TLR5, TNF
43
Show member pathways
7.8IFNG, IFNGR1, IL1B, LTA, TLR4, TLR5
44
Show member pathways
7.8IFNG, IFNGR1, IL1B, LTA, TLR4, TLR5
45
Show member pathways
7.8CASP1, IL1B, LTA, TLR4, TLR5, TNF
46
Show member pathways
7.5CASP1, F2, IFNG, IFNGR1, IL1B, TLR4
47
Show member pathways
7.4CASP1, IFNG, IFNGR1, IL1B, LTA, TLR4
48
Show member pathways
6.9CASP1, F2, IFNG, IFNGR1, IL1B, LTA
49
Show member pathways
6.5CASP1, CRP, IFNG, IFNGR1, IL1B, LTA

GO Terms for genes affiliated with Typhoid Fever

About this section

Biological processes related to Typhoid Fever according to GeneCards Suite gene sharing:

(show all 49)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of interleukin-8 biosynthetic processGO:004541610.5TLR4, TNF
2positive regulation of chemokine productionGO:003272210.5TLR4, TNF
3negative regulation of interleukin-17 productionGO:003270010.5IFNG, TLR4
4positive regulation of interleukin-12 biosynthetic processGO:004508410.5IFNG, TLR4
5sequestering of triglycerideGO:003073010.5IL1B, TNF
6regulation of establishment of endothelial barrierGO:190314010.5IL1B, TNF
7positive regulation of cytokine productionGO:000181910.4SLC11A1, TNF
8positive regulation of interleukin-6 biosynthetic processGO:004541010.4IFNG, IL1B
9negative regulation of growth of symbiont in hostGO:004413010.4IFNG, TNF
10positive regulation of interleukin-12 productionGO:003273510.4IFNG, TLR4
11positive regulation of fever generationGO:003162210.4IL1B, TNF
12negative regulation of lipid catabolic processGO:005099510.4IL1B, TNF
13negative regulation of interleukin-6 productionGO:003271510.4TLR4, TNF
14negative regulation of extrinsic apoptotic signaling pathway in absence of ligandGO:200124010.4IL1B, TNF
15regulation of I-kappaB kinase/NF-kappaB signalingGO:004312210.3IL1B, TNF
16positive regulation of stress-activated MAPK cascadeGO:003287410.3IL1B, TLR4
17positive regulation of MHC class II biosynthetic processGO:004534810.3IFNG, TLR4
18positive regulation of osteoclast differentiationGO:004567210.3IFNG, TNF
19positive regulation of cytokine secretionGO:005071510.2CASP1, TNF
20positive regulation of nitric oxide biosynthetic processGO:004542910.2IL1B, TLR5, TNF
21positive regulation of calcidiol 1-monooxygenase activityGO:006055910.1IFNG, IL1B, TNF
22positive regulation of membrane protein ectodomain proteolysisGO:005104410.1IFNG, IL1B, TNF
23positive regulation of NF-kappaB import into nucleusGO:004234610.1IL1B, TLR4, TNF
24interleukin-1 beta productionGO:003261110.1CASP1, IL1B
25positive regulation of chemokine biosynthetic processGO:004508010.1IFNG, IL1B, TNF
26response to ATPGO:003319810.1CASP1, IL1B
27protein import into nucleus, translocationGO:000006010.1IFNG, SLC11A1, TNF
28positive regulation of interleukin-1 beta secretionGO:005071810.1CASP1, IFNG
29positive regulation of interleukin-8 productionGO:003275710.0IL1B, TLR4, TLR5
30positive regulation of chronic inflammatory response to antigenic stimulusGO:000287610.0LTA, TNF
31positive regulation of phagocytosisGO:005076610.0IL1B, SLC11A1, TNF
32activation of MAPK activityGO:000018710.0IL1B, TLR4, TNF
33positive regulation of JUN kinase activityGO:00435079.9IL1B, TNF
34regulation of insulin secretionGO:00507969.9IFNG, IL1B, TNF
35extrinsic apoptotic signaling pathwayGO:00971919.9IFNG, TLR4, TNF
36positive regulation of interleukin-6 productionGO:00327559.8IL1B, TLR4, TNF
37negative regulation of gene expressionGO:00106299.8IFNG, IL1B, TNF
38leukocyte migrationGO:00509009.6F2, IL1B, TNF
39defense response to Gram-positive bacteriumGO:00508309.5CRP, LTA, TNF
40defense response to bacteriumGO:00427429.3IFNG, TLR4, TLR5, TNF
41positive regulation of apoptotic processGO:00430659.3IL1B, LTA, TNF
42inflammatory responseGO:00069549.2CRP, IL1B, SLC11A1, TLR5, TNF
43immune responseGO:00069559.1IFNG, IL1B, SLC11A1, TLR4, TNF
44cellular response to lipopolysaccharideGO:00712229.1IFNG, IL1B, TLR4, TLR5, TNF
45positive regulation of interferon-gamma productionGO:00327298.9IL1B, LTA, SLC11A1, TLR4, TNF
46positive regulation of transcription from RNA polymerase II promoterGO:00459448.8IFNG, IL1B, SLC11A1, TLR4, TNF
47positive regulation of gene expressionGO:00106288.8CRP, IFNG, IL1B, SLC11A1, TLR4
48cellular response to mechanical stimulusGO:00712608.7CASP1, F2, IL1B, TLR4, TLR5
49response to lipopolysaccharideGO:00324968.1CASP1, IL1B, LTA, SLC11A1

Sources for Typhoid Fever

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet